The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?
Open accessAbstract
BACKGROUND: Fatigue is a major complaint of multiple sclerosis (MS) patients. However, little is known about its pathophysiological mechanisms. Evidence from chronic fatigue syndrome and studies on sickness behaviour suggest that immune and neuroendocrine factors may play a causative role in the development of fatigue. METHODS: We compared whole blood stimulatory capacity for pro- (TNFalpha, IFNgamma) and anti-inflammatory cytokines (IL-10) as well as hypothalamo-pituitary-adrenal (HPA) axis function in 15 MS patients with marked fatigue and 15 patients without fatigue as determined by the Fatigue Severity Scale (FSS). RESULTS: Proinflammatory cytokines were significantly higher (TNFalpha: 478.9 v 228.2 pg/ml, p = 0.01; IFNgamma: 57.6 v 27.8 pg/ml; p = 0.01) in MS patients with fatigue. Furthermore, TNFalpha values significantly correlated with daytime sleepiness as measured by the Epworth Sleepiness Scale (r = 0.64, p = 0.001). Controlling for disease activity (as measured by the Cambridge Multiple Sclerosis Basic Score), disease duration, Expanded Disability Status Scale, and depression further increased the correlation of cytokine production and fatigue. HPA axis activity was not related to fatigue but was modestly correlated with cognitive impairment. CONCLUSION: Our data suggest that fatigue in MS is at least partially mediated through activation of proinflammatory cytokines. In line with earlier findings, HPA axis dysfunction seems not to be relevant in MS fatigue pathogenesis but appears to be linked to cognitive impairment. Our findings suggest that increased levels of inflammatory cytokines may be involved in MS fatigue. Investigation of cytokine profiles may increase the understanding of fatigue pathogenesis in MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
Krupp, L. B. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520460115022 · Cited by 6,172
New Multiple Sclerosis Phenotypic Classification
Lublin, F. D. (2014) · European Neurology · doi:10.1159/000367614 · Cited by 4,259
Defining the clinical course of multiple sclerosis: Results of an international survey
Lublin, F. D., Reingold, S. C., & National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis* (1996) · Neurology · doi:10.1212/wnl.46.4.907 · Cited by 3,686
Quantification of Sleepiness: A New Approach
Hoddes, E., Zarcone, V., Smythe, H., Phillips, R., & Dement, W. C. (1973) · Psychophysiology · doi:10.1111/j.1469-8986.1973.tb00801.x · Cited by 2,538
von Büdingen, H.-C., Palanichamy, A., Lehmann-Horn, K., Michel, B. A., & Zamvil, S. S. (2015) · European Neurology · doi:10.1159/000377675 · Cited by 1,463
Smith, A. (2016) · PsycTESTS Dataset · doi:10.1037/t27513-000 · Cited by 1,277
Vgontzas, A. N., Papanicolaou, D. A., Bixler, E. O., Hopper, K. D., Lotsikas, A. J., LIN, H., Kales, A., & Chrousos, G. P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.1151 · Cited by 1,199
Cytokine-induced sickness behaviour: mechanisms and implications
Konsman, J. P., Parnet, P., & Dantzer, R. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02088-9 · Cited by 999
Vgontzas, A. N., Zoumakis, E., Lin, H.-M., Bixler, E. O., Trakada, G., & Chrousos, G. P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031929 · Cited by 341
Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS?
Téllez, N., Río, J., Tintoré, M., Nos, C., Galán, I., & Montalban, X. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1148oa · Cited by 299
A Cytokine-Based Neuroimmunologic Mechanism of Cancer-Related Symptoms
Lee, B.-N., Dantzer, R., Langley, K. E., Bennett, G. J., Dougherty, P. M., Dunn, A. J., Meyers, C. A., Miller, A. H., Payne, R., Reuben, J. M., et al. (2004) · Neuroimmunomodulation · doi:10.1159/000079408 · Cited by 294
Fatigue in multiple sclerosis: current understanding and future directions.
Schwid, S. R., Covington, M., Segal, B. M., & Goodman, A. D. (2002) · PubMed · Cited by 267
Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern
Kroencke, D. C., Lynch, S. G., & Denney, D. R. (2000) · Multiple Sclerosis Journal · doi:10.1177/135245850000600213 · Cited by 253
The HPA axis and the genesis of chronic fatigue syndrome
Cleare, A. J. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2003.12.002 · Cited by 224
Fassbender, K., Schmidt, R., Mößner, R., Kischka, U., Kühnen, J., Schwartz, A., & Hennerici, M. (1998) · Archives of Neurology · doi:10.1001/archneur.55.1.66 · Cited by 204
Cytokine mRNA expression in patients with multiple sclerosis and fatigue
Flachenecker, P., Bihler, I., Weber, F., Gottschalk, M., Toyka, K. V., & Rieckmann, P. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms991oa · Cited by 169
Fatigue and Regulation of the Hypothalamo-Pituitary-Adrenal Axis in Multiple Sclerosis
Gottschalk, M., Kümpfel, T., Flachenecker, P., Uhr, M., Trenkwalder, C., Holsboer, F., & Weber, F. (2005) · Archives of Neurology · doi:10.1001/archneur.62.2.277 · Cited by 166
von Bardeleben, U., & Holsboer, F. (1989) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1989.tb00150.x · Cited by 161
Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS
Bergh, F. T., Kümpfel, T., Trenkwalder, C., Rupprecht, R., & Holsboer, F. (1999) · Neurology · doi:10.1212/wnl.53.4.772 · Cited by 128
Gold, P. W., Gabry, K. E., Yasuda, M. R., & Chrousos, G. P. (2002) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(01)00022-6 · Cited by 121
Fatigue is not associated with raised inflammatory markers in multiple sclerosis
Giovannoni, G., Thompson, A. J., Miller, D. H., & Thompson, E. J. (2001) · Neurology · doi:10.1212/wnl.57.4.676 · Cited by 116
Heesen, C., Gold, S. M., Raji, A., Wiedemann, K., & Schulz, K. (2002) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00071-3 · Cited by 87
Self-citationEndocrine and cytokine responses to standardized physical stress in multiple sclerosis
Heesen, C., Gold, S. M., Hartmann, S., Mladek, M., Reer, R., Braumann, K.-M., Wiedemann, K., & Schulz, K. (2003) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(03)00077-1 · Cited by 79
Self-citationGrasser, A., Möller, A., Backmund, H., Yassouridis, A., & Holsboer, F. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211419 · Cited by 69
Endocrine and Cytokine Responses to Acute Psychological Stress in Multiple Sclerosis
Heesen, C., Schulz, H., Schmidt, M., Gold, S. M., Tessmer, W., & Schulz, K. (2002) · Brain Behavior and Immunity · doi:10.1006/brbi.2001.0628 · Cited by 64
Self-citationNeuroendocrine Aspects of Chronic Fatigue Syndrome
Papanicolaou, D. A., Amsterdam, J. D., Levine, S. M., McCann, S. M., Moore, R. C., Newbrand, C. H., Allen, G., Nisenbaum, R. A., Pfaff, D. W., Tsokos, G. C., et al. (2004) · NeuroImmunoModulation · doi:10.1159/000075315 · Cited by 55
Problems with rating scales for multiple sclerosis: a novel approach ? the CAMBS score
Mumford, C. J., & Compston, A. (1993) · Journal of Neurology · doi:10.1007/bf00818706 · Cited by 51
Altered cytokine responses to cognitive stress in multiple sclerosis patients with fatigue
Heesen, C., Koehler, G., Gross, R., Tessmer, W., Schulz, K., & Gold, S. M. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1129oa · Cited by 43
Self-citationDiagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Cited by
Reciprocal regulation of the neural and innate immune systems
Irwin, M. R., & Cole, S. W. (2011) · Nature Reviews Immunology · doi:10.1038/nri3042 · Cited by 910
“and in individuals with inflammatory diseases such as multiple sclerosi”
BackgroundD'Mello, C., Le, T., & Swain, M. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3567-08.2009 · Cited by 675
The Role of Inflammation in Depression and Fatigue
Lee, C.-H., & Giuliani, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01696 · Cited by 640
TNF-α suppresses the expression of clock genes by interfering with E-box-mediated transcription
Cavadini, G., Petrzilka, S., Kohler, P., Jud, C., Tobler, I., Birchler, T., & Fontana, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701466104 · Cited by 421
Fatigue as a symptom or comorbidity of neurological diseases
Penner, I.-K., & Paul, F. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.117 · Cited by 404
Metadata
- Authors
- Heesen, C.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2006-01-01
- Volume
- 77
- Issue
- 1
- Pages
- 34-39
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2153084624
- Cited by
- 345
- References
- 33
- FWCI
- 6.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.